{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "Transmisi\u00f3n vertical",
      "Vertical transmission"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [
    {
      "AbstractText": [
        "Efectuar una revisi\u00f3n sistem\u00e1tica de estudios originales revisados por pares que contengan datos acerca de la identificaci\u00f3n de SARS-CoV-2 en muestras cl\u00ednicas de l\u00edquido amni\u00f3tico, placenta o membranas, sangre del cord\u00f3n umbilical y leche humana de mujeres con diagn\u00f3stico cl\u00ednico o confirmado de COVID-19. Para ser incluidos en esta revisi\u00f3n sistem\u00e1tica, los estudios debieron ser aceptados despu\u00e9s de la publicaci\u00f3n de la gu\u00eda para el manejo de pacientes con COVID-19 de la Organizaci\u00f3n Mundial de la Salud (disponible el 13 de marzo de 2020).",
        "Se incluyeron 17 estudios en los que se identificaron 143 muestras cl\u00ednicas (38 de l\u00edquido amni\u00f3tico, 34 de placentas o membranas, 39 de sangre del cord\u00f3n umbilical y 32 de leche humana), de las cuales nueve resultaron positivas para ARN de SARS-CoV-2 (una de l\u00edquido amni\u00f3tico obtenida antes de romper las membranas; seis de placenta o membranas, aunque los autores indican la posibilidad de contaminaci\u00f3n por sangre materna en tres de ellas; y dos de leche humana).",
        "Siguiendo nuestros criterios de b\u00fasqueda no encontramos estudios que demuestren la detecci\u00f3n de SARS-CoV-2, a la par del aislamiento viral y la evaluaci\u00f3n de la capacidad infectiva de las part\u00edculas virales, en muestras cl\u00ednicas de l\u00edquido amni\u00f3tico, placenta o membranas, sangre del cord\u00f3n umbilical y leche humana, de mujeres con diagn\u00f3stico cl\u00ednico o confirmado de COVID-19. Sin embargo, la transmisi\u00f3n vertical no puede descartarse y se requieren estudios de mayor tama\u00f1o que empleen idealmente t\u00e9cnicas de localizaci\u00f3n <i>in situ</i> de ARN y prote\u00edna de SARS-CoV-2, as\u00ed como de aislamiento viral que compruebe la capacidad infectiva de las part\u00edculas virales."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 SESPAS. Publicado por Elsevier Espa\u00f1a, S.L.U. All rights reserved."
    }
  ],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "32711871",
  "DateCompleted": {
    "Year": "2022",
    "Month": "03",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "02",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2020",
        "Month": "06",
        "Day": "20"
      }
    ],
    "Language": [
      "spa"
    ],
    "ELocationID": [
      "10.1016/j.gaceta.2020.06.005",
      "S0213-9111(20)30137-0"
    ],
    "Journal": {
      "ISSN": "1578-1283",
      "JournalIssue": {
        "Volume": "36",
        "Issue": "2",
        "PubDate": {
          "Year": "2022",
          "Season": "Mar-Apr"
        }
      },
      "Title": "Gaceta sanitaria",
      "ISOAbbreviation": "Gac Sanit"
    },
    "ArticleTitle": "[Review of new evidence about the possible vertical transmission of coronavirus disease-2019].",
    "Pagination": {
      "StartPage": "166",
      "EndPage": "172",
      "MedlinePgn": "166-172"
    },
    "Abstract": {
      "AbstractText": [
        "To conduct a systematic review of original peer-reviewed studies, containing data on the identification of SARS-CoV-2 in clinical samples of amniotic fluid, placenta or membranes, umbilical cord blood, and human milk, from women with a clinically or confirmed diagnosis of COVID-19. These studies should have been published after the guide for the management of patients with COVID-19 from World Health Organization guide (available in March 13, 2020).",
        "Seventeen studies were included, in which 143 clinical samples were identified (38 of amniotic fluid; 34 of placentas or membranes; 39 from umbilical cord blood and 32 from human milk). Among the 143 samples, nine were positive for SARS-CoV-2 RNA (one amniotic fluid sample obtained before rupturing the membranes; six samples of placenta or membranes, although authors indicate the possibility of contamination by maternal blood in three of these, and two samples of human milk).",
        "Following our search criteria, we found no studies that demonstrate the detection of SARS-CoV-2, in conjunction with viral isolation and the evaluation of the infective capacity of viral particles, in clinical samples of amniotic fluid, placenta or membranes, umbilical cord blood and human milk, from women with a confirmed or clinical diagnosis of COVID-19. However, vertical transmission cannot be ruled out, larger studies are required that ideally locate in situ RNA and protein of SARS-CoV-2, as well as isolation that demonstrate the infective capacity of the viral particles."
      ],
      "CopyrightInformation": "Copyright \u00a9 2020 SESPAS. Publicado por Elsevier Espa\u00f1a, S.L.U. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto de Salud P\u00fablica, Universidad Veracruzana, Xalapa, Veracruz, M\u00e9xico. Electronic address: csampieri@uv.mx."
          }
        ],
        "LastName": "Sampieri",
        "ForeName": "Clara Luz",
        "Initials": "CL"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Instituto de Salud P\u00fablica, Universidad Veracruzana, Xalapa, Veracruz, M\u00e9xico."
          }
        ],
        "LastName": "Montero",
        "ForeName": "Hilda",
        "Initials": "H"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review",
      "Systematic Review"
    ],
    "VernacularTitle": "Revisi\u00f3n de nuevas evidencias acerca de la posible transmisi\u00f3n vertical de la COVID-19."
  },
  "MedlineJournalInfo": {
    "Country": "Spain",
    "MedlineTA": "Gac Sanit",
    "NlmUniqueID": "8901623",
    "ISSNLinking": "0213-9111"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Viral"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pregnancy"
    },
    {
      "QualifierName": [],
      "DescriptorName": "RNA, Viral"
    },
    {
      "QualifierName": [],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}